Regulation 3 Amendment of the Misuse of Drugs Regulations 2001
In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after “Methylnaphthidate (HDMP-28)” insert—
“N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA)”.